WO2006088962A3 - Replikin peptides and uses thereof - Google Patents

Replikin peptides and uses thereof Download PDF

Info

Publication number
WO2006088962A3
WO2006088962A3 PCT/US2006/005343 US2006005343W WO2006088962A3 WO 2006088962 A3 WO2006088962 A3 WO 2006088962A3 US 2006005343 W US2006005343 W US 2006005343W WO 2006088962 A3 WO2006088962 A3 WO 2006088962A3
Authority
WO
WIPO (PCT)
Prior art keywords
peptides
new class
replikin peptides
therapeutics
diagnosing
Prior art date
Application number
PCT/US2006/005343
Other languages
French (fr)
Other versions
WO2006088962A9 (en
WO2006088962A2 (en
Inventor
Samuel Bogoch
Elenore S Bogoch
Samuel Winston Bogoch
Anne-Elenore Bogoch Borsanyi
Original Assignee
Samuel Bogoch
Elenore S Bogoch
Samuel Winston Bogoch
Anne-Elenore Bogoch Borsanyi
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/US2005/014443 external-priority patent/WO2005104754A2/en
Application filed by Samuel Bogoch, Elenore S Bogoch, Samuel Winston Bogoch, Anne-Elenore Bogoch Borsanyi filed Critical Samuel Bogoch
Priority to AU2006214332A priority Critical patent/AU2006214332B2/en
Priority to EP06735145A priority patent/EP1859063A4/en
Priority to NZ560415A priority patent/NZ560415A/en
Priority to JP2007555371A priority patent/JP2008539164A/en
Priority to CA002598381A priority patent/CA2598381A1/en
Publication of WO2006088962A2 publication Critical patent/WO2006088962A2/en
Publication of WO2006088962A9 publication Critical patent/WO2006088962A9/en
Priority to IL185308A priority patent/IL185308A0/en
Publication of WO2006088962A3 publication Critical patent/WO2006088962A3/en

Links

Classifications

    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B30/00—ICT specially adapted for sequence analysis involving nucleotides or amino acids
    • G16B30/10—Sequence alignment; Homology search
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B30/00—ICT specially adapted for sequence analysis involving nucleotides or amino acids

Abstract

The present invention provides a new class of peptides related to rapid replication and high human mortality, and their use in diagnosing, preventing and treating disease including vaccines and therapeutics for emerging viral diseases and methods of identifying the new class of peptides and related structures.
PCT/US2006/005343 2005-02-16 2006-02-16 Replikin peptides and uses thereof WO2006088962A2 (en)

Priority Applications (6)

Application Number Priority Date Filing Date Title
AU2006214332A AU2006214332B2 (en) 2005-02-16 2006-02-16 Replikin peptides and uses thereof
EP06735145A EP1859063A4 (en) 2005-02-16 2006-02-16 Replikin peptides and uses thereof
NZ560415A NZ560415A (en) 2005-02-16 2006-02-16 Systems and method for identifying replikin scaffolds and uses of said replikin scaffolds
JP2007555371A JP2008539164A (en) 2005-02-16 2006-02-16 Replikin peptide and use thereof
CA002598381A CA2598381A1 (en) 2005-02-16 2006-02-16 Replikin peptides and uses thereof
IL185308A IL185308A0 (en) 2005-02-16 2007-08-16 Replikin peptides and uses thereof

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US65308305P 2005-02-16 2005-02-16
US60/653,083 2005-02-16
USPCT/US2005/014443 2005-04-28
PCT/US2005/014443 WO2005104754A2 (en) 2004-04-28 2005-04-28 System and method for identifying complex patterns of amino acids

Publications (3)

Publication Number Publication Date
WO2006088962A2 WO2006088962A2 (en) 2006-08-24
WO2006088962A9 WO2006088962A9 (en) 2006-11-16
WO2006088962A3 true WO2006088962A3 (en) 2008-01-24

Family

ID=36917023

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2006/005343 WO2006088962A2 (en) 2005-02-16 2006-02-16 Replikin peptides and uses thereof

Country Status (8)

Country Link
EP (1) EP1859063A4 (en)
JP (1) JP2008539164A (en)
AU (1) AU2006214332B2 (en)
CA (1) CA2598381A1 (en)
IL (1) IL185308A0 (en)
NZ (1) NZ560415A (en)
SG (1) SG160327A1 (en)
WO (1) WO2006088962A2 (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7420028B2 (en) 2001-03-27 2008-09-02 Samuel Bogoch Replikins and methods of identifying replikin-containing sequences
US7682619B2 (en) 2006-04-06 2010-03-23 Cornell Research Foundation, Inc. Canine influenza virus
AU2007319669A1 (en) * 2006-05-30 2008-05-22 Elenore S. Bogoch Replikin peptides and uses thereof
WO2008140557A2 (en) * 2006-10-24 2008-11-20 Samuel Bogoch A method of predicting influenza outbreaks
WO2008143717A2 (en) 2007-01-18 2008-11-27 Samuel Bogoch Methods of determining lethality of pathogens and malignancies involving replikin peak genes
EP2594578A1 (en) * 2007-05-30 2013-05-22 Samuel Bogoch Replikin peptides directed against pathogenic infections of invertebrates in aquaculture
AU2009240587A1 (en) * 2008-04-23 2009-10-29 Bogoch, Elenore S. Methods and compounds for mitigating pathogenic outbreaks using replikin count cycles
WO2010017514A2 (en) * 2008-08-08 2010-02-11 Samuel Bogoch Methods of predicting cancer lethality using replikin counts
US9233148B2 (en) * 2009-01-09 2016-01-12 Samuel Bogoch Replikin-based compounds for prevention and treatment of influenza and methods of differentiating infectivity and lethality in influenza
NZ595812A (en) * 2009-04-23 2013-09-27 Samuel Bogoch Replikin-sequences for preventing/treating influenza and determining infectivity/lethality
EP2734226A2 (en) 2011-07-20 2014-05-28 Samuel Bogoch Peptides shared among lethal cancers and therapeutic compositions comprising said peptides
SG11201405447QA (en) 2012-03-09 2014-10-30 Samuel Bogoch Therapies, vaccines, and predictive methods for infectious salmon anemia virus

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0221748A3 (en) 1985-11-01 1988-10-12 Samuel Dr. Bogoch A process for the production of human antibodies
US4946778A (en) 1987-09-21 1990-08-07 Genex Corporation Single polypeptide chain binding molecules
US6242578B1 (en) 1994-02-17 2001-06-05 Samuel Bogoch Aglyco products and methods of use
US7442761B2 (en) * 2003-06-06 2008-10-28 Samuel Bogoch Replikin peptides and uses thereof
US7420028B2 (en) * 2001-03-27 2008-09-02 Samuel Bogoch Replikins and methods of identifying replikin-containing sequences
US11620305B2 (en) 2021-03-25 2023-04-04 Salesforce.Com, Inc Ruleset engine for generating homogeneous data sets

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
DATABASE PROTEIN [online] XP008115267, accession no. NCBI Database accession no. (AAK38298) *
YASUKO A.-O. ET AL.: "Intranasal administration of adjuvant-combined recombinant influenza virus HA vaccine protects mice from the lethal H5N1 virus infection", MICROBES AND INFECTION, vol. 8, no. 12-13, October 2006 (2006-10-01), pages 2706 - 2714, XP005852354, Retrieved from the Internet <URL:http://www.sciencedirect.com/science/article/B6VPN-4KRY1SP-1/2/2c1efa90441346327644c5a057c4e50f> *

Also Published As

Publication number Publication date
IL185308A0 (en) 2008-02-09
CA2598381A1 (en) 2006-08-24
SG160327A1 (en) 2010-04-29
AU2006214332B2 (en) 2012-03-22
JP2008539164A (en) 2008-11-13
WO2006088962A9 (en) 2006-11-16
NZ560415A (en) 2010-05-28
EP1859063A4 (en) 2012-02-01
AU2006214332A1 (en) 2006-08-24
EP1859063A2 (en) 2007-11-28
WO2006088962A2 (en) 2006-08-24

Similar Documents

Publication Publication Date Title
WO2006088962A3 (en) Replikin peptides and uses thereof
WO2005010032A3 (en) Replikin peptides and uses thereof
IL291162A (en) Isolated human rpe cells and use thereof for the treatment of degenerative diseases of the retina
WO2006060314A3 (en) Generation of replication competent viruses for therapeutic use
WO2009044273A3 (en) Use of recombinant lag-3 or the derivatives thereof for eliciting monocyte immune response
IL189500A (en) 5-substituted- pyrimidine-2,4-diamimes, pharmaceutical compositions comprising them and their use in the manufacture of a medicament for treatment of p2x3 and p2x2/3 recepror mediated disease
WO2006035237A3 (en) Methods and compositions relating to alzheimer&#39;s disease
UA94221C2 (en) Lipocalin protein
JP2007536277A5 (en)
PA8772101A1 (en) IMIDAZOL-TRIAZOLOPIRIMIDINAS REPLACED
WO2005116076A3 (en) Neoplasm-specific polypeptides and their uses
WO2006121610A3 (en) Personal care compositions and methods for their use
ATE453642T1 (en) SUBSTITUTED PHENYLAMINOPYRIMIDINES
WO2008106646A3 (en) Methods and formulations for topical gene therapy
DK2276485T3 (en) USE OF EPOTHILON D IN TREATMENT OF TAU-ASSOCIATED DISEASES, INCLUDING ALZHEIMER&#39;S DISEASE
BRPI0816255A2 (en) Pharmaceutical product, use of the product, method for the prophylaxis or treatment of diseases, and pharmaceutically acceptable composition.
UY29952A1 (en) PHARMACEUTICAL COMPOSITIONS THAT INCLUDE 4- (4-FLUORO-2-METHYL-1H-INDOL-5-ILOXI) -6-METOXI-7- (3- (PIRROLIDIN-1-IL) PROPOXI) QUINAZOLINE OR A PHARMACEUTICALLY ACCEPTABLE SALT OF THE SAME , PREPARATION AND USE PROCESSES
TW200801031A (en) Steroid nitrooxyderivatives
AR058173A1 (en) USE OF SDF-1 FOR THE TREATMENT AND / OR PREVENTION OF NEUROLOGICAL DISEASES
WO2006091841A3 (en) Compositions and their uses directed to il-4r alpha
WO2010041252A3 (en) Use of a cinnamon bark extract for treating amyloid-associated diseases
PA8806501A1 (en) TRIAZOLOTRIAZINAS AND TRIAZOLOPIRAZINAS AND ITS USE
CL2008001563A1 (en) COMPOUNDS DERIVED FROM BENZODIOXANES CONDENSED WITH HETEROCICLES; PREPARATION METHOD; PHARMACEUTICAL COMPOSITION; AND USE IN THE TREATMENT OF DISEASES SUCH AS DEPRESSION, ANXIETY, PANIC CRISIS, AMONG OTHERS.
WO2008137733A3 (en) Micellar structures, methods of making micellar structures, methods of imaging, and methods of delivering agents
ZA200803445B (en) 6-heteroarylpyridoindolone derivatives, their preparation and therapeutic use thereof

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 560415

Country of ref document: NZ

WWE Wipo information: entry into national phase

Ref document number: 2006214332

Country of ref document: AU

WWE Wipo information: entry into national phase

Ref document number: 2007555371

Country of ref document: JP

ENP Entry into the national phase

Ref document number: 2598381

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: 185308

Country of ref document: IL

NENP Non-entry into the national phase

Ref country code: DE

ENP Entry into the national phase

Ref document number: 2006214332

Country of ref document: AU

Date of ref document: 20060216

Kind code of ref document: A

WWE Wipo information: entry into national phase

Ref document number: 2006735145

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 3473/KOLNP/2007

Country of ref document: IN

DPE1 Request for preliminary examination filed after expiration of 19th month from priority date (pct application filed from 20040101)
DPE1 Request for preliminary examination filed after expiration of 19th month from priority date (pct application filed from 20040101)